STOCKWATCH
·
Medical/Dental Instruments
Loan & DebtMay 12, 2026, 08:07 AM

CVRx Q1 Revenue $14.77M; Secures $50M Debt Increase & New ATM

AI Summary

CVRx, Inc. reported Q1 2026 revenue of $14.77 million, an increase from $12.35 million in the prior year, while also reducing its net loss to $(13.12) million. The company significantly enhanced its financial flexibility by amending its Loan Agreement to increase available term loans by $50.0 million to an aggregate of $100.0 million and extending the maturity to 2031, with an immediate draw of $10.0 million. Additionally, CVRx entered into a new Open Market Sale Agreement to potentially raise up to $50.0 million through an at-the-market common stock offering.

Key Highlights

  • Amended Loan Agreement, increasing available term loans by $50.0M to $100.0M.
  • Extended debt maturity date to 2031 and borrowed an additional $10.0M.
  • Entered new ATM offering agreement to sell up to $50.0M in common stock.
  • Q1 2026 Revenue increased to $14.77M from $12.35M in Q1 2025.
  • Q1 2026 Net Loss improved to $(13.12)M from $(13.77)M in Q1 2025.
  • Q1 2026 Net Loss per share improved to $(0.50) from $(0.53) in Q1 2025.
  • Cash and cash equivalents were $72.30M as of March 31, 2026.
  • Long-term debt increased to $58.49M as of March 31, 2026.
CVRX
Medical/Dental Instruments
CVRx, Inc.

Price Impact